Terms: = Pancreatic cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
131 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
4. Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G; Levine MF; Roberts SS; Cheung IY; Medina-Martínez JS; Feng Y; Arango-Ossa JE; Chadoutaud L; Rita M; Asimomitis G; Zhou J; You D; Bouvier N; Spitzer B; Solit DB; Dela Cruz F; LaQuaglia MP; Kushner BH; Modak S; Shukla N; Iacobuzio-Donahue CA; Kung AL; Cheung NV; Papaemmanuil E
Nat Genet; 2023 Jun; 55(6):1022-1033. PubMed ID: 37169874
[TBL] [Abstract] [Full Text] [Related]
5. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10.
Qi J; Li J; Bie B; Shi M; Zhu M; Tian J; Zhu K; Sun J; Mu Y; Li Z; Guo Y
Phytother Res; 2023 Jan; 37(1):295-309. PubMed ID: 36070933
[TBL] [Abstract] [Full Text] [Related]
6. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer.
Malhotra L; Sharma S; Hariprasad G; Dhingra R; Mishra V; Sharma RS; Kaur P; Ethayathulla AS
Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119343. PubMed ID: 36007676
[TBL] [Abstract] [Full Text] [Related]
7. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
8. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1270-1278. PubMed ID: 35604485
[TBL] [Abstract] [Full Text] [Related]
9. Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.
Liu P; Zhong Q; Song Y; Guo D; Ma D; Chen B; Lan J; Liu Q
Int J Biol Sci; 2022; 18(7):2932-2948. PubMed ID: 35541917
[TBL] [Abstract] [Full Text] [Related]
10. Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in pancreatic cancer via Degradation of Ferritin Heavy Chain and Mutant p53.
Li J; Lama R; Galster SL; Inigo JR; Wu J; Chandra D; Chemler SR; Wang X
Mol Cancer Ther; 2022 Apr; 21(4):535-545. PubMed ID: 35131878
[TBL] [Abstract] [Full Text] [Related]
11. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Liang J; Li G; Liao J; Huang Z; Wen J; Wang Y; Chen Z; Cai G; Xu W; Ding Z; Liang H; Datta PK; Chu L; Chen X; Zhang B
Cell Death Differ; 2022 May; 29(5):988-1003. PubMed ID: 35034103
[TBL] [Abstract] [Full Text] [Related]
12. Effects of the mdm2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53.
Abrams SL; Akula SM; Steelman LS; Follo ML; Cocco L; Ratti S; Martelli AM; Libra M; Falzone L; Candido S; Montalto G; Cervello M; Lombardi P; McCubrey JA
Adv Biol Regul; 2022 Jan; 83():100840. PubMed ID: 34866036
[TBL] [Abstract] [Full Text] [Related]
13. ALKBH5-mediated m
He Y; Yue H; Cheng Y; Ding Z; Xu Z; Lv C; Wang Z; Wang J; Yin C; Hao H; Chen C
Cell Death Dis; 2021 Dec; 12(12):1121. PubMed ID: 34853296
[TBL] [Abstract] [Full Text] [Related]
14. USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression.
Ren D; Sun Y; Li D; Wu H; Jin X
Mol Oncol; 2022 Mar; 16(5):1200-1217. PubMed ID: 34743406
[TBL] [Abstract] [Full Text] [Related]
15. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical cancer Care.
Chakraborty S; Ecker BL; Seier K; Aveson VG; Balachandran VP; Drebin JA; D'Angelica MI; Kingham TP; Sigel CS; Soares KC; Vakiani E; Wei AC; Chandwani R; Gonen M; Shen R; Jarnagin WR
Clin Cancer Res; 2021 Nov; 27(21):5891-5899. PubMed ID: 34433650
[TBL] [Abstract] [Full Text] [Related]
16. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, mdm2, MDM4, p53, KRAS and AKT in renal cell carcinoma.
Li F; Aljahdali IAM; Zhang R; Nastiuk KL; Krolewski JJ; Ling X
J Exp Clin Cancer Res; 2021 Aug; 40(1):254. PubMed ID: 34384473
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA HCG11/miR-579-3p/mdm2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
Xu J; Xu W; Yang X; Liu Z; Sun Q
Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
[TBL] [Abstract] [Full Text] [Related]
18. Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.
Wang K; Li L; Franch-Expósito S; Le X; Tang J; Li Q; Wu Q; Bassaganyas L; Camps J; Zhang X; Li H; Foukakis T; Xiang T; Wu J; Ren G
Mol Oncol; 2022 Jun; 16(12):2413-2431. PubMed ID: 34146382
[TBL] [Abstract] [Full Text] [Related]
19. Valosin-Containing Protein Stabilizes Mutant p53 to Promote pancreatic cancer Growth.
Wang J; Chen Y; Huang C; Hao Q; Zeng SX; Omari S; Zhang Y; Zhou X; Lu H
Cancer Res; 2021 Aug; 81(15):4041-4053. PubMed ID: 34099490
[TBL] [Abstract] [Full Text] [Related]
20. ITPKA induces cell senescence, inhibits ovarian cancer tumorigenesis and can be downregulated by miR-203.
Shaosheng W; Shaochuang W; Lichun F; Na X; Xiaohong Z
Aging (Albany NY); 2021 Apr; 13(8):11822-11832. PubMed ID: 33879633
[TBL] [Abstract] [Full Text] [Related]
[Next]
